Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 19:3:9.
doi: 10.1186/1755-8794-3-9.

Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density

Margarethe Biong  1 , Inger T Gram, Ilene Brill, Fredrik Johansen, Hiroko K Solvang, Grethe I G Alnaes, Toril Fagerheim, Yngve Bremnes, Stephen J Chanock, Laurie Burdett, Meredith Yeager, Giske Ursin, Vessela N Kristensen
Affiliations

Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density

Margarethe Biong et al. BMC Med Genomics. .

Abstract

Background: Increased mammographic density is one of the strongest independent risk factors for breast cancer. It is believed that one third of breast cancers are derived from breasts with more than 50% density. Mammographic density is affected by age, BMI, parity, and genetic predisposition. It is also greatly influenced by hormonal and growth factor changes in a woman's life cycle, spanning from puberty through adult to menopause. Genetic variations in genes coding for hormones and growth factors involved in development of the breast are therefore of great interest. The associations between genetic polymorphisms in genes from the IGF pathway on mammographic density and circulating levels of IGF1, its binding protein IGFBP3, and their ratio in postmenopausal women are reported here.

Methods: Samples from 964 postmenopausal Norwegian women aged 55-71 years were collected as a part of the Tromsø Mammography and Breast Cancer Study. All samples were genotyped for 25 SNPs in IGF1, IGF2, IGF1R, IGF2R, IGFALS and IGFBP3 using Taqman (ABI). The main statistical analyses were conducted with the PROC HAPLOTYPE procedure within SAS/GENETICS (SAS 9.1.3).

Results: The haplotype analysis revealed six haploblocks within the studied genes. Of those, four had significant associations with circulating levels of IGF1 or IGFBP3 and/or mammographic density. One haplotype variant in the IGF1 gene was found to be associated with mammographic density. Within the IGF2 gene one haplotype variant was associated with levels of both IGF1 and IGFBP3. Two haplotype variants in the IGF2R were associated with the level of IGF1. Both variants of the IGFBP3 haplotype were associated with the IGFBP3 level and indicate regulation in cis.

Conclusion: Polymorphisms within the IGF1 gene and related genes were associated with plasma levels of IGF1, IGFBP3 and mammographic density in this study of postmenopausal women.

PubMed Disclaimer

References

    1. Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230:29–41. doi: 10.1148/radiol.2301020870. - DOI - PubMed
    1. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6:798–808. doi: 10.1016/S1470-2045(05)70390-9. - DOI - PubMed
    1. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87:1622–1629. doi: 10.1093/jnci/87.21.1622. - DOI - PubMed
    1. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M. Effects of mammographic density and benign breast disease on breast cancer risk (United States) Cancer Causes Control. 2001;12:103–110. doi: 10.1023/A:1008935821885. - DOI - PubMed
    1. Byrne C. Studying mammographic density: implications for understanding breast cancer. J Natl Cancer Inst. 1997;89:531–533. doi: 10.1093/jnci/89.8.531. - DOI - PubMed

Publication types

MeSH terms

Substances